Showing results (1-10 of 1,067) with videos related to
Sort By:
Pageof 107
British Journal of Cancer|March 27, 2018
Long-term follow-up of overall survival for cabozantinib versus everolimus in advanced renal cell carcinomaRobert J Motzer, Bernard Escudier, Thomas Powles, et al.The Oncologist|March 30, 2026
Cardiac Biomarkers in Patients With Renal Cell Carcinoma Treated With Immune Checkpoint InhibitorsYen-Chou Chen, Mandar A Aras, Brian I Rini, et al.The Oncologist|January 27, 2024
The Relationship Between Health-Related Quality of Life and Overall Survival in Patients With Advanced Renal Cell Carcinoma in CheckMate 214David Cella, Toni K Choueiri, Melissa Hamilton, et al.Current Opinion in Investigational Drugs (London, England : 2000)|June 3, 2008
Axitinib, a novel anti-angiogenic drug with promising activity in various solid tumorsToni K ChoueiriJournal of the National Comprehensive Cancer Network : JNCCN|May 25, 2013
Clinical treatment decisions for advanced renal cell cancerToni K ChoueiriClinical Genitourinary Cancer|May 27, 2008
Factors associated with outcome in patients with advanced renal cell carcinoma in the era of antiangiogenic agentsToni K ChoueiriCurrent Clinical Pharmacology|August 11, 2011
VEGF inhibitors in metastatic renal cell carcinoma: current therapies and future perspectiveToni K ChoueiriEuropean Journal of Cancer (Oxford, England : 1990)|November 3, 2022
Nivolumab plus ipilimumab plus cabozantinib triplet combination for patients with previously untreated advanced renal cell carcinoma: Results from a discontinued arm of the phase III CheckMate 9ER trialAndrea B Apolo, Thomas Powles, Bernard Escudier, et al.Urologic Oncology|November 19, 2013
Precision medicine for metastatic renal cell carcinomaGuru Sonpavde, Toni K ChoueiriNature Clinical Practice. Oncology|June 26, 2008
Chemotherapy for muscle-invasive bladder cancer treated with definitive radiotherapy: persisting uncertaintiesToni K Choueiri, Derek RaghavanPageof 107